Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluative Study on Predicting the Primary Site of Metastatic Tumors Using Transcriptomic Profiling for Tumor Tissue Origin Identification

NCT07319949 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07319949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07319949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluative Study on Predicting the Primary Site of Metastatic Tumors Using Transcriptomic Profiling for Tumor Tissue Origin Identification
Lead sponsor
Fudan University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
October 13, 2026
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cup, malignant tumor with metastasis